Female Health - 20 Year Stock Price History | VERU

Historical daily share price chart and data for Female Health since 1999 adjusted for splits. The latest closing stock price for Female Health as of November 12, 2019 is 1.92.
  • The all-time high Female Health stock closing price was 10.01 on June 18, 2013.
  • The Female Health 52-week high stock price is 2.49, which is 29.7% above the current share price.
  • The Female Health 52-week low stock price is 1.18, which is 38.5% below the current share price.
  • The average Female Health stock price for the last 52 weeks is 1.74.
Female Health Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 1.7840 1.4000 2.3600 1.2000 1.9200 37.14%
2018 1.6894 1.4300 2.2900 1.1900 1.4000 22.81%
2017 1.2490 0.9200 2.8400 0.9200 1.1400 25.27%
2016 1.3604 1.4500 2.6500 0.8200 0.9100 -37.24%
2015 2.3115 3.9000 3.9200 1.3200 1.4500 -63.01%
2014 5.5094 8.3800 8.4200 3.3200 3.9200 -53.88%
2013 8.5816 7.3200 10.0100 6.7000 8.5000 18.38%
2012 6.0546 4.7200 8.2700 4.7200 7.1800 59.20%
2011 4.7320 5.7200 5.8600 3.8100 4.5100 -20.74%
2010 5.6446 4.8300 7.3800 4.4200 5.6900 20.30%
2009 4.7005 3.9600 7.6500 2.8700 4.7300 33.24%
2008 2.6503 2.5500 3.7200 1.9500 3.5500 36.02%
2007 2.2834 1.5200 3.6000 1.4600 2.6100 69.48%
2006 1.4567 1.7000 1.7800 1.1900 1.5400 -10.47%
2005 1.6932 1.9500 2.1000 1.3200 1.7200 -14.00%
2004 2.4625 2.7000 3.5000 1.5000 2.0000 -27.27%
2003 1.9176 1.6000 2.8400 1.4000 2.7500 77.42%
2002 1.5111 0.7100 2.1600 0.7000 1.5500 106.67%
2001 0.5508 0.4700 0.8000 0.3400 0.7500 59.57%
2000 0.7100 1.1200 1.2500 0.3800 0.4700 -60.50%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.131B $0.016B
Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.090B 27.01
Medtronic (MDT) Ireland $143.599B 20.16
Stryker (SYK) United States $74.738B 25.13
Boston Scientific (BSX) United States $56.464B 26.65
Baxter (BAX) United States $40.084B 24.31
EssilorLuxottica Societe Anonyme (ESLOY) France $32.664B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.619B 18.58
Terumo (TRUMY) Japan $27.722B 0.00
Lonza Group Ag (LZAGY) Switzerland $25.691B 0.00
Coloplast (CLPBY) Denmark $25.121B 0.00
ResMed (RMD) United States $20.684B 38.16
Sunny Optical Technology (SNPTF) China $18.592B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $18.588B 0.00
Bio-Rad Laboratories (BIO) United States $10.550B 50.64
Insulet (PODD) United States $10.476B 498.41
Canopy Growth (CGC) Canada $7.475B 0.00
Hill-Rom Holdings (HRC) United States $6.947B 20.47
Perrigo (PRGO) Ireland $6.812B 12.70
William Demant Holdings (WILYY) Denmark $6.665B 0.00
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $6.037B 40.79
GN STORE NORD (GNNDY) Denmark $5.276B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $5.155B 0.00
Aurora Cannabis (ACB) Canada $3.920B 0.00
NuVasive (NUVA) United States $3.757B 29.59
ICU Medical (ICUI) United States $3.456B 22.41
GW Pharmaceuticals (GWPH) United Kingdom $3.380B 0.00
Neogen (NEOG) United States $3.369B 56.38
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.987B 0.00
Quidel (QDEL) United States $2.480B 23.54
National Vision Holdings (EYE) United States $2.179B 49.55
Agios Pharmaceuticals (AGIO) United States $1.976B 0.00
Cardiovascular Systems (CSII) United States $1.570B 0.00
InMode (INMD) Israel $1.293B 0.00
Aphria (APHA) $1.275B 0.00
VAREX IMAGING (VREX) United States $1.245B 28.70
AtriCure (ATRC) United States $1.109B 0.00
Phibro Animal Health (PAHC) United States $0.936B 17.53
Eagle Pharmaceuticals (EGRX) United States $0.863B 22.01
Lantheus Holdings (LNTH) United States $0.842B 21.04
NanoString Technologies (NSTG) United States $0.826B 0.00
TG Therapeutics (TGTX) United States $0.775B 0.00
Omeros (OMER) United States $0.669B 0.00
LeMaitre Vascular (LMAT) United States $0.662B 37.49
PetIQ (PETQ) United States $0.655B 16.01
HEXO (HEXO) $0.604B 0.00
Quanterix (QTRX) United States $0.589B 0.00
Cerus (CERS) United States $0.577B 0.00
Organigram Holdings (OGI) Canada $0.572B 0.00
OraSure Technologies (OSUR) United States $0.529B 31.74
Surmodics (SRDX) United States $0.527B 54.97
Owens & Minor (OMI) United States $0.454B 16.79
MacroGenics (MGNX) United States $0.404B 0.00
Utah Medical Products (UTMD) United States $0.383B 27.79
BioLife Solutions (BLFS) United States $0.341B 104.75
Meridian Bioscience (VIVO) United States $0.337B 11.62
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.328B 0.00
Zynex (ZYXI) United States $0.295B 33.33
Viemed Healthcare (VMD) United States $0.266B 0.00
Bovie Medical (APYX) United States $0.238B 0.00
United Health Products (UEEC) United States $0.185B 0.00
Vapotherm (VAPO) United States $0.183B 0.00
Repro-Med Systems (KRMD) United States $0.172B 0.00
Cytosorbents (CTSO) United States $0.149B 0.00
InfuSystems Holdings (INFU) United States $0.142B 0.00
Liberty Health Sciences (LHSIF) Canada $0.133B 0.00
Fonar (FONR) United States $0.126B 8.87
Rockwell Medical (RMTI) United States $0.118B 0.00
Chimerix (CMRX) United States $0.101B 0.00
United-Guardian (UG) United States $0.085B 21.62
Chembio Diagnostics (CEMI) United States $0.080B 0.00
Nephros (NEPH) United States $0.072B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
MRI Interventions (MRIC) United States $0.053B 0.00
Surface Oncology (SURF) United States $0.048B 0.00
MTech Acquisition (KERN) United States $0.046B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.020B 0.00
Senestech (SNES) United States $0.019B 0.00
Myomo (MYO) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Akers Biosciences Inc (AKER) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00